📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Americas Cell Counting Market Analysis

ID: MRFR//0135-HCR | 51 Pages | Author: Kinjoll Dey| July 2024

The cell counting market in the Americas is seeing ceaseless mechanical progressions. Advancements, for example, mechanized cell counters, stream cytometers, and image-based cell counting frameworks are acquiring visibility. This innovative advancement is driving the market, offering more exact and productive cell counting arrangements.
The far-reaching growth of the biopharmaceutical business in the Americas is a significant driver for the cell counting market. The expanded interest for cell-based treatments, biologics, and antibody creation requires exact cell counting, supporting the reception of cutting-edge counting advances in the locale.
The Americas have become a center point for foundational microorganism research, with a developing emphasis on regenerative medication and customized treatments. This uplifted interest on foundational microorganism research is filling the interest for modern cell counting techniques to precisely measure and portray different cell types.
The accessibility of significant financing for life sciences research is assuming a vital part in driving the cell counting market forward. Research foundations, biotech organizations, and academic labs in the Americas are putting resources into state-of-the-art cell counting advancements for different applications, encouraging market growth.
The cell counting market is extending its impression in clinical diagnostics, driven by the requirement for exact cell includes in regions, for example, malignant growth diagnostics, illness monitoring, and resilient framework appraisals. This expansion of utilizations is expanding the market scope.
There is an outstanding movement towards computerized cell counting frameworks in the Americas. Robotized stages offer higher throughput, precision, and reproducibility contrasted with manual counting strategies. This pattern is reshaping lab work processes, improving effectiveness, and impacting market elements.
The reception of 3D cell culture techniques is picking up speed in the Americas, especially in drug disclosure and toxicology studies. This change in cell culture practices requires progressed cell counting strategies able to do precisely surveying cell suitability and expansion in three-dimensional environments.

Covered Aspects:

Report Attribute/Metric Details

Americas Cell Counting Market Overview

Americas Cell Counting Market Size was valued at USD 3.71 Billion in 2023. The Global Americas Cell Counting industry is projected to grow from USD 3.97 Billion in 2024 to USD 6.94 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.82% during the forecast period (2024 - 2032). Cell counting is one of the method for the counting the cells in the life sciences, including medical diagnosis and treatment. It is an important subset of cytometry, with applications in research and clinical practice.

It is an important process in the field of life sciences, including medical diagnosis and treatment and biological research. For researchers, cell counting is a major step in most experimental workflows, helping them to maintain cell cultures, prepare cells for transfection and downstream experiments. Researchers often need to count cells prior to cell culture or before studying downstream processes and using analytical techniques that require an accurate number of input cells.

Drivers for increase in cell counting market in America is quality cell health system, increased importance of cell counting and wide range of cell counting applications. Furthermore, growing out of pocket expenditure and use of enhanced data visualization and analysis software led to market growth.

Intended Audience:

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Pharmaceutical Companies

  • Biotechnology Companies

  • Academic Medical Institutes and Universities

Americas Cell Counting Market Segment Insights

Americas Cell Counting Instruments Insights

On the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments. 

Americas Cell Counting Application Insights

On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications. 

Americas Cell Counting End Users Insights

On the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations

Americas Cell Counting Regional Isights

On the basis of region Americas market is divided into North America, and South America. North America consists of U.S, Canada, Mexico and Rest of North America. North America is the largest market for cell counting which is expected to grow at a CAGR of 9.3% and is expected to reach at US$ 5.4 billion. This is due to presence of prominent cell counting market players, rising prevalence of chronic diseases and highly developed healthcare system. The U.S. accounts for the largest market for cell counting in North America.  

South America is second largest market for cell counting whose growth is driven by improved diagnosis and treatment methods favor the rising demand of this market. Improved technology in the manufacturing of cell counting instruments further enhance the growth of this market. 

Key Players for Cell Counting Market

Some of the key players in this market are:

  • Bio-Rad Laboratories Inc. (U.S)

  • General Electric Company (U.S)

  • Agilent Technologies (U.S)

  • PerkinElmer Inc. (U.S)

  • Tecan Trading AG (Switzerland)

  • BioTek Instruments, Inc. (U.S)

  • Danaher (U.S)

  • Merck KGaA (U.S)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.